Barclays
XAGE

Barclays’s Longevity Health Holdings, Inc. Common Stock XAGE Stock Holding History

Barclays’s Portfolio XAGE Stock Details XAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-243
Closed -$911 – 5638
2025
Q1 		$911 Buy
+243
New +$2.36K ﹤0.01% 5055

Other funds holding XAGE

Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CMU
Carnegie Mellon University Pittsburgh, Pennsylvania $64.3M AUM 35.71% 1-Year Est. Return
GSWM
Golden State Wealth Management Santa Ana, California $915M AUM 19.16% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Barclays's XAGE Position: Q2 2025 in Review

Barclays sold out of Longevity Health Holdings, Inc. Common Stock (XAGE) in Q2 2025, closing a stake of 243 shares — an estimated $911 sold.

Barclays first reported a position in XAGE in Q1 2025 and held it in 1 quarter. The position peaked at $911 in Q1 2025. 11 funds tracked by Wall St. Rank hold XAGE as of Q2 2025.

  • Barclays reported no remaining Longevity Health Holdings, Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
  • Barclays sold 243 Longevity Health Holdings, Inc. Common Stock shares in Q2 2025, an estimated $911.
  • Barclays first reported a position in Longevity Health Holdings, Inc. Common Stock in Q1 2025 and held it in 1 quarter.
  • Barclays's Longevity Health Holdings, Inc. Common Stock position peaked at $911 in Q1 2025.
  • 11 funds tracked by Wall St. Rank held Longevity Health Holdings, Inc. Common Stock as of Q2 2025.

Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.